Clinical Conversation: Outcomes in Patients With Pulmonary Embolism Treated With Mechanical Thrombectomy or Anticoagulation Alone

Program Description

Pulmonary embolism (PE) is a leading cause of cardiovascular death; little data exist on whether mechanical thrombectomy confers a mortality benefit. Using a retrospective review, 311 consecutive patients with PE who underwent aspiration thrombectomy were compared to 309 propensity score-matched patients with PE treated with anticoagulation alone. This clinical conversation discusses the results of this retrospective review.

Faculty and Program

	Sahil A. Parikh, MD, FSCAI Moderator		Hassan Saleh, MD Presenting Author
	Peter Monteleone, MD, FSCAI Panelist		Kenneth Rosenfield Panelist

Learning Objectives

At the end of this activity, participants should be able to: 

Evaluate the mortality benefit of mechanical thrombectomy compared to anticoagulation alone in patients with pulmonary embolism using a retrospective review.
Assess the impact of patient risk stratification on outcomes, particularly in high-risk versus low-risk pulmonary embolism patients.
Analyze the incidence of adverse events, including bleeding, stroke, and recurrent pulmonary embolism, in patients undergoing thrombectomy versus anticoagulation alone.

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Inari, now part of Stryker.

Summary

Availability:

On-Demand

Access expires on Dec 22, 2028

Cost:

FREE

Credit Offered:

0.25 Participation Credit